- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01262508
Development of Algorithms to Predict Hemodynamic Instability
February 18, 2016 updated by: Klinik für Kardiologie, Pneumologie und Angiologie
Development of Algorithms to Detect and Predict Hemodynamic Instability in Patients at Risk
Hemodynamic monitoring in hospitalized patients is crucial since in clinical practice unexpected deterioration of cardiovascular function remains a serious problem and an important cause of death.
Novel perspectives in reflex testing of the autonomic nervous system might be useful to protect some patients from cardiovascular events by detecting cardiovascular deteriorations.
In addition, standard pulse oximetry in low acuity settings is nowadays predominately used to monitor peripheral oxygen saturation.
Of note, there is evidence that additional analyses of pulse wave characteristics might be a valuable source of information to generate additional insights into the cardiorespiratory status of the patient.
Herein, we aim to develop novel algorithms in order to protect in-hospital patients from cardiovascular events in consequence of hemodynamic instability in the future.
Study Overview
Status
Completed
Conditions
Detailed Description
70 datasets from hospitalized patients will be acquired in order to characterize the functional status of the autonomic nervous system as well as hemodynamics during baseline and during standard procedures including physical exercise testing and head-up tilt table testing.
Autonomic reflex testing:
- Heart Rate Characteristics
- Heart Rate Variability
- Heart Rate Turbulence
- Blood Pressure Variability
- Baroreflex Sensitivity
- Hyperoxic Chemoreflex Sensitivity
Hemodynamic Monitoring:
- Heart Rate Trends
- Blood Pressure Trends
- Pulse Wave Characteristics
- Cardiac Output
- Peripheral Vascular Resistance
- Context information
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
NRW
-
Duesseldorf, NRW, Germany, 40225
- Heinrich-Heine-University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients being at risk of sudden cardiac death
Description
Inclusion Criteria:
- hospitalization
- Age > 17 years
Exclusion Criteria:
- documented diseases of the central nervous system
- impairment of mental health
- age > 85 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Risk Population
Patients being suspected to be at risk of hemodynamic instability due to medical history
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Autonomic Dysfunction
Time Frame: 24 hours
|
Dysfunction of the autonomic nervous system as assessed by autonomic reflex testing
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hemodynamic Deterioration
Time Frame: 24 hours
|
Acute hemodynamic changes (Blood pressure changes > 10 mm Hg, heart rate changes > 5 bpm both within 30 seconds) of a patient as assessed by hemodynamic monitoring
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Christian Meyer, MD, University of Duesseldorf
- Study Director: Malte Kelm, MD, PhD, University of Duesseldorf
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Jungen C, Zeus T, Balzer J, Eickholt C, Petersen M, Kehmeier E, Veulemans V, Kelm M, Willems S, Meyer C. Left Atrial Appendage Closure Guided by Integrated Echocardiography and Fluoroscopy Imaging Reduces Radiation Exposure. PLoS One. 2015 Oct 14;10(10):e0140386. doi: 10.1371/journal.pone.0140386. eCollection 2015.
- Drexel T, Eickholt C, Muhlsteff J, Ritz A, Siekiera M, Kirmanoglou K, Schulze V, Shin DI, Balzer J, Rassaf T, Kelm M, Meyer C. Vagal heart rate control in patients with atrial fibrillation: impact of tonic activation of peripheral chemosensory function in heart failure. Adv Exp Med Biol. 2013;755:287-97. doi: 10.1007/978-94-007-4546-9_37.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
April 1, 2015
Study Completion (Actual)
April 1, 2015
Study Registration Dates
First Submitted
December 16, 2010
First Submitted That Met QC Criteria
December 16, 2010
First Posted (Estimate)
December 17, 2010
Study Record Updates
Last Update Posted (Estimate)
February 19, 2016
Last Update Submitted That Met QC Criteria
February 18, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Autonomics - Prediction
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sudden Cardiac Death
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of British Columbia; Alberta Health... and other collaboratorsCompleted
-
University Hospital Southampton NHS Foundation...WithdrawnCardiac Arrest | Sudden Death, Cardiac
-
Solae, LLCProvident Clinical ResearchCompletedCardiovascular Disease | Sudden Cardiac Death | Sudden Cardiac Arrest
-
Zoll Medical CorporationTerminatedSudden Cardiac Death | Sudden Cardiac ArrestUnited States
-
Solae, LLCProvident Clinical ResearchCompletedCardiovascular Disease | Sudden Cardiac Death | Sudden Cardiac ArrestUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceRecruitingHeart Failure | Implantable Cardioverter Defibrillator | Primary Prevention of Sudden Cardiac DeathFrance
-
Zoll Medical CorporationCompletedHeart Failure | Sudden Cardiac Death | Sudden Cardiac Arrest | Heart Failure Low OutputFrance, United States, Germany, Austria
-
University of LuebeckProf. Jürgen Kuschyk, M.D; Giovanni Forleo, M.D.; Mauro Biffi, M.D.RecruitingSudden Cardiac DeathGermany
-
Deutsches Herzzentrum MuenchenCompletedSudden Cardiac DeathGermany
-
Jingfeng WangFudan University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University... and other collaboratorsEnrolling by invitation